key: cord-0717681-u6hdfl6m authors: MILLER, Hayley E.; HENKEL, Andrea; LEONARD, Stephanie A.; MILLER, Sarah E.; TRAN, Linh; BIANCO, Katherine; SHAW, Kate A. title: The impact of the COVID-19 pandemic on postpartum contraception planning date: 2021-05-28 journal: Am J Obstet Gynecol MFM DOI: 10.1016/j.ajogmf.2021.100412 sha: 9f623825740b51e117d2b67395b2abd638c9e249 doc_id: 717681 cord_uid: u6hdfl6m nan The COVID-19 pandemic necessitated rapid adjustment of obstetric delivery models including fewer antenatal appointments and increased use of telehealth. We hypothesized the response to the COVID-19 pandemic decreased the proportion of people with a postpartum contraception plan at the time of the birth-hospitalization admission and the uptake of top-tier forms of contraception by the routine postpartum visit, which has otherwise been increasing in recent years. 1, 2 Study Design: We conducted a cohort study comparing a randomly selected sample of people giving birth at an academic center during a regional "shelter in place" order, March 16 to July 31, 2020, to a previously abstracted random sample of people delivering between November 1, 2017 and April 30, 2018. The Stanford University Institutional Review Board reviewed and approved this study before its initiation. The study was powered to detect a 10% difference in the proportion of those arriving at birth-hospitalization with a contraceptive plan (power 80%, alpha 0.05). The final sample size included 586 people (318 in the pre-COVID cohort and 268 in the COVID cohort). We conducted a multivariable modified Poisson regression model to estimate the relative risk of arriving at birth-hospitalization with a contraceptive plan in pre-COVID versus COVID cohorts, adjusting for age, parity, insurance status, and delivery mode. Secondary outcomes included: tier of contraception plan and provision at admission, discharge, and postpartum visit (classified by WHO Tiered-Effectiveness 3 ), attendance at postpartum visit, and whether the postpartum visit was conducted via telehealth. We used Fisher's exact test to compare the secondary outcomes. At birth-hospitalization admission, a smaller proportion of people had a postpartum contraceptive plan in the COVID cohort than in the pre-COVID cohort (73.9% vs 99.4%, aRR 0.87, 95% CI: 0.84, 0.91, p<0.001). A smaller proportion of people had a plan for top-tier contraception among the COVID cohort compared to pre-COVID cohort at both admission and discharge (46.0% vs. 71.0%, p<0.001 and 31.0% vs 37.9%, p=0.05) (Figure 1 ). More than 80% of people attended a routine postpartum visit in both cohorts (p=0.30) with 17.7% being telehealth visits in COVID cohort as compared to telehealth not being offered pre-COVID. Among those who attended their postpartum visit, the proportion discharged with a plan for interval top-tier contraception that was fulfilled was high in both groups (76.3% pre vs 71.2% post, p=0.56). We found a significant decrease in people arriving at birth-hospitalization with a contraception plan in the months following a COVID-19 "shelter in place" order when compared to a pre-COVID cohort. We suspect that obstetric service model changes indirectly deprioritized the most effective forms of postpartum contraception since sterilization requires a signed consent prior to birth-hospitalization and post-placental intrauterine devices require consent prior to delivery. 4, 5 Given changes in care models due to COVID-19 with decreased in-person postpartum follow-up, actualizing patients' contraceptive preferences is increasingly more dependent on inpatient provision. This study is inherently limited by its retrospective nature of review and additional qualitative studies may better characterize this trend in contraceptive uptake. In the meantime, obstetric care providers should carefully evaluate institutional barriers to postpartum contraception during this movement to telehealth. All authors revised and approved the manuscript. American College of Obstetrics and Gynecologists Postpartum contraception: Optimizing interpregnancy intervals World Health Organization/Department of Reproductive Health and Research (WHO/RHR) Johns Hopkins Bloomberg School of Public Health (JHSPH)/Center for Communication Programs (CCP). Family planning: a global handbook for providers Baltimore (MD): CCP COVID-19 highlights the policy barriers and complexities of postpartum sterilization Contraceptive counseling and postpartum contraceptive use Figure 1: Comparison of contraception plan among pre-COVID (n=318) and COVID (n=268) cohorts at time of birth hospitalization admission, discharge, and at postpartum visit The authors report no conflicts of interest. No financial support of this study and no funding received. Data are n% WHO Tiered-Effectiveness 3 as top-tier: female or male sterilization, implant, intrauterine device (light gray), mid-tier: pills, ring, patch, injection (dark gray), low-tier: condoms (red), or undecided/declined (black).Excluded patients without a contraceptive plan documented or applicable at admission for birth hospitalization.